The global anti-ageing market was estimated to be worth about 62.6 billion US dollars in 2021 and it is projected to grow at a compound annual rate of almost 7% from 2022. Tech Giants, like Google and Amazon, have started to set their foot in the longevity sector with billions of investments.
Bonerge Lifescience has witnessed the expansion of the anti-ageing market and announced the debut of its branded ingredient - BeFisetinTM. BeFisetinTM, which targets ageing at a cellular level, is one of the easily accessible ways to achieve healthy ageing. The ingredient is controlled under a full-supply chain management system to provide high-quality fisetin with quality assurance. BeFisetinTM is manufactured in state-of-the-art cGMP facilities and is strictly verified by Reference Standard from Sigma-Aldrich.
Fisetin has been wandering around in the supplements market for years and was often marketed as one neuroprotection supplement. Since the discovery of senolytics in 2015, Fisetin has gained rising popularity in the anti-ageing market as the research-proven most powerful natural senolytic. With ageing, senescent cells accumulate in different organs and cause harm to their surrounding cells. Removing senescent cells, the major function of senolytics, is a promising anti-ageing and health trick. Besides anti-ageing, some of the noteworthy health benefits of fisetin are promoting hair growth, supporting bone health, and reducing the impacts of diabetes.
Fisetin is commonly used for supplements. It can be used as a solo active ingredient or added to a well-designed formula to achieve synergistic health benefits. Notably, many brands are starting to explore the possibilities of fisetin with cosmetics, pet supplements, and beverages. BeFisetinTM, the golden standard of fisetin, is committed to consistently supporting the Fisetin products.
For more information, visit befisetin.com